Patients should continue established psoriasis treatments and discuss eligibility for GLP-1 therapy based on metabolic indications with their doctor
As with any peptide or hormone-based treatment, side effects such as nausea, increased freckles or mole changes, and flushing can occur
Thirst and fluid intake are closely linked to urine production
Stop immediately and contact your doctor if: Severe neck swelling or a palpable thyroid mass develops Symptoms of thyrotoxicosis appear: rapid heartbeat, severe anxiety, excessive sweating, tremor, sudden unexplained weight loss Severe pancreatitis symptoms: intense upper abdominal pain radiating to the back with nausea and vomiting You discover you are pregnant Discuss with your endocrinologist if: TSH levels become unstable despite levothyroxine adjustments New thyroid nodules appear on follow-up ultrasound Hair loss is severe and persistent despite adequate nutrient levels Fatigue worsens despite thyroid levels appearing normal Autoimmune flare frequency appears to increase You reach your target weight and want to explore discontinuation For patients who achieve their weight loss goals and want to stop GLP-1 therapy, tapering is recommended over abrupt discontinuation
FAQ What exactly is a GLP-1 Medication
CJC -1295 NO DAC (Mod GRF 1-29) 5mg $39.90 Modified GRF is a truncated peptide analogue of growth hormone releasing hormone (GHRH)